Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 4, Pages 884
Publisher
MDPI AG
Online
2021-02-22
DOI
10.3390/cancers13040884
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interim thymus and activation regulated chemokine versus interim 18 F‐fluorodeoxyglucose positron‐emission tomography in classical Hodgkin lymphoma response evaluation
- (2020) Wouter J. Plattel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thymus and Activation-regulated Chemokine as a Biomarker for IgG4-related Disease
- (2020) Masataka Umeda et al. Scientific Reports
- Thymus and activation-regulated chemokine (TARC/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease
- (2020) Hiroyoshi Machida et al. ALLERGOLOGY INTERNATIONAL
- Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET ‐adapted strategy
- (2020) Simonetta Viviani et al. HEMATOLOGICAL ONCOLOGY
- Thymus and activation‐regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis
- (2020) Yurika Kawasaki et al. JOURNAL OF DERMATOLOGY
- Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma
- (2020) Filip Janku et al. CLINICAL CANCER RESEARCH
- Evaluation of the Diagnostic Accuracy of Thymus and Activation-Regulated Chemokine to Discriminate Food Protein-Induced Enterocolitis Syndrome from Infectious Gastroenteritis
- (2020) Eishi Makita et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study
- (2020) Kentaro Yonekura et al. Blood Advances
- Serum levels of TARC, MDC, IL10 and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study
- (2019) Eric D. Hsi et al. BLOOD
- Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
- (2019) Tomohiro Aoki et al. Cancer Discovery
- Hodgkin lymphoma cell lines: to separate the wheat from the chaff
- (2018) Hans G. Drexler et al. BIOLOGICAL CHEMISTRY
- Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
- (2018) Enrico Tiacci et al. BLOOD
- Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies
- (2018) Anja Mottok et al. BLOOD
- CD4 + CD52 lo T-cell expression contributes to the development of systemic lupus erythematosus
- (2018) Masataka Umeda et al. CLINICAL IMMUNOLOGY
- Thymus and activation-regulated chemokine (TARC)/CCL17 and IgE are associated with elderly asthmatics
- (2018) Kyung Mi Jo et al. Immunity & Ageing
- The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation
- (2018) Takayoshi Komatsu-Fujii et al. ALLERGOLOGY INTERNATIONAL
- Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma
- (2017) A. Guidetti et al. LEUKEMIA RESEARCH
- Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
- (2017) Jonathan B. Reichel et al. Jove-Journal of Visualized Experiments
- Biomarker assessment in chronic rhinitis and chronic rhinosinusitis: Endothelin-1, TARC/CCL17, neopterin, and α-defensins
- (2016) Namjil N. Tsybikov et al. ALLERGY AND ASTHMA PROCEEDINGS
- Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC
- (2016) Wouter J. Plattel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis
- (2016) Jianing Wang et al. CYTOKINE
- Treatment of relapsed and refractory Hodgkin Lymphoma
- (2016) Bastian von Tresckow et al. SEMINARS IN HEMATOLOGY
- CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma
- (2016) Annarosa Cuccaro et al. Cancer Medicine
- CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma
- (2015) Takumi Kumai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Biomarkers for atopic dermatitis
- (2015) Judith Thijs et al. Current Opinion in Allergy and Clinical Immunology
- Nivolumab shows clinical activity in Hodgkin's lymphoma
- (2015) Sanjeet Bagcchi LANCET ONCOLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
- (2014) J. Reichel et al. BLOOD
- Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: Potential as a serum biomarker
- (2014) Jong-Baeck Lim et al. CANCER SCIENCE
- Anti-CCR4 Monoclonal Antibody Mogamulizumab for the Treatment of EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
- (2014) T. Kanazawa et al. CLINICAL CANCER RESEARCH
- Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis
- (2014) Yoko Kataoka JOURNAL OF DERMATOLOGY
- The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing
- (2014) Y Liu et al. LEUKEMIA
- Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata
- (2013) Shigeki Inui et al. JOURNAL OF DERMATOLOGY
- Pathology of asthma
- (2013) Makoto Kudo et al. Frontiers in Microbiology
- Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma
- (2012) Maike Sauer et al. AMERICAN JOURNAL OF HEMATOLOGY
- Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma
- (2012) C. Steidl et al. BLOOD
- Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma
- (2012) K. Jones et al. CLINICAL CANCER RESEARCH
- Mogamulizumab
- (2012) Joshuan M. Subramaniam et al. DRUGS
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Hodgkin's lymphoma in adults
- (2012) William Townsend et al. LANCET
- Marketing approval of mogamulizumab
- (2012) Alain Beck et al. mAbs
- Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma
- (2011) W. J. Plattel et al. HAEMATOLOGICA
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels
- (2011) T. Miyagaki et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517
- (2011) Mark H. Kirschbaum et al. LEUKEMIA & LYMPHOMA
- Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis
- (2011) Tania Diaz et al. PLoS One
- Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) A. Engert et al. ANNALS OF ONCOLOGY
- Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
- (2010) S. M. Castellino et al. BLOOD
- Second Malignant Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low-Dose Radiation and Chemotherapy
- (2010) Maureen M. O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges
- (2010) Laurence Delhaes et al. MEDICAL MYCOLOGY
- T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
- (2009) A. Di Stasi et al. BLOOD
- HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells
- (2009) Nils Schoof et al. Cell Communication and Signaling
- Mutations ofNFKBIA, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases
- (2009) Annette Lake et al. INTERNATIONAL JOURNAL OF CANCER
- Increases in Serum TARC/CCL17 Levels Are Associated with Progression-Free Survival in Advanced Melanoma Patients in Response to Dendritic Cell-Based Immunotherapy
- (2009) Andrew N. Cornforth et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Vorinostat in solid and hematologic malignancies
- (2009) David Siegel et al. Journal of Hematology & Oncology
- Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
- (2008) D. Buglio et al. BLOOD
- Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22
- (2008) Marijke Niens et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
- (2007) Antonella Viola et al. Annual Review of Pharmacology and Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now